Terms: = Breast cancer AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70
85536 results:
1. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.
Sharma R; Yadav V; Jha S; Dighe S; Jain S
Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723
[TBL] [Abstract] [Full Text] [Related]
2. Disparities in quality of life among patients with breast cancer based on surgical methods: a cross-sectional prospective study.
Wang Y; He Y; Wu S; Xie S
Sci Rep; 2024 May; 14(1):11364. PubMed ID: 38762615
[TBL] [Abstract] [Full Text] [Related]
3. Effect of gradient pressure therapy on the prevention of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Dongxue G; Fangfei Z; Ran L; Lizhi Z
Support Care Cancer; 2024 May; 32(6):367. PubMed ID: 38761270
[TBL] [Abstract] [Full Text] [Related]
4. The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age.
Boutrus RR; Abdelazim YA; Mohammed T; Bayomy M; Ibraheem MH; Hussein A; Sebaie ME
BMC Cancer; 2024 May; 24(1):599. PubMed ID: 38760780
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
6. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
[TBL] [Abstract] [Full Text] [Related]
7. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract] [Full Text] [Related]
9. A pilot randomised controlled trial of acceptance and commitment therapy for medication decision-making and quality of life in women with breast cancer: The ACTION trial.
Graham CD; Ellison R; Hall LH; Clark J; McNaught E; Green SMC; Wilkes H; Robson G; Lorentz I; Holmes L; Bould N; Hartley S; Naik J; Buckley S; Hirst C; Hartup S; Foy R; Neal RD; Velikova G; Farrin A; Collinson M; Smith SG
Psychooncology; 2024 May; 33(5):e6349. PubMed ID: 38752788
[TBL] [Abstract] [Full Text] [Related]
10. Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial.
Hauner D; Mang A; Donik L; Schederecker F; Meyer D; Rack B; Janni W; Hauner H
BMC Cancer; 2024 May; 24(1):591. PubMed ID: 38750410
[TBL] [Abstract] [Full Text] [Related]
11. Practice of breast self-examination and associated factors among women of reproductive age in the North Shoa Zone, Oromia, Ethiopia, 2022: a convergent mixed-methods study.
Hussein D; Oyato BT; Gashaw K; Geleta TA; Tufa DG; Geleta LA
BMJ Open; 2024 May; 14(5):e073951. PubMed ID: 38749697
[TBL] [Abstract] [Full Text] [Related]
12. Association between red cell distribution width and all-cause mortality in patients with breast cancer: A retrospective analysis using MIMIC-IV 2.0.
Xiao J; Tan L; Pei Y; Yang R; Li J; Feng Y; Feng J
PLoS One; 2024; 19(5):e0302414. PubMed ID: 38748743
[TBL] [Abstract] [Full Text] [Related]
13. A meta-analysis of MRI radiomics-based diagnosis for BI-RADS 4 breast lesions.
Lin J; Zheng H; Jia Q; Shi J; Wang S; Wang J; Ge M
J Cancer Res Clin Oncol; 2024 May; 150(5):254. PubMed ID: 38748373
[TBL] [Abstract] [Full Text] [Related]
14. Posttranslational protein modifications as gatekeepers of cancer immunogenicity.
Marchese E; Demehri S
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747288
[TBL] [Abstract] [Full Text] [Related]
15. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract] [Full Text] [Related]
16. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
Romaní-Cubells E; Martínez-Erro S; Morales V; Chocarro-Calvo A; García-Martínez JM; Sanz R; García-Jiménez C; García-Muñoz RA
J Nanobiotechnology; 2024 May; 22(1):249. PubMed ID: 38745193
[TBL] [Abstract] [Full Text] [Related]
17. An Immersive Virtual Reality Intervention for Preoperative Anxiety and Distress Among Adults Undergoing Oncological Surgery: Protocol for a 3-Phase Development and Feasibility Trial.
El-Gabalawy R; Sommer JL; Hebbard P; Reynolds K; Logan GS; Smith MSD; Mutter TC; Mutch WA; Mota N; Proulx C; Gagnon Shaigetz V; Maples-Keller JL; Arora RC; Perrin D; Benedictson J; Jacobsohn E
JMIR Res Protoc; 2024 May; 13():e55692. PubMed ID: 38743939
[TBL] [Abstract] [Full Text] [Related]
18. Comparison efficacy and safety of acupuncture and moxibustion therapies in breast cancer-related lymphedema: A systematic review and network meta-analysis.
Xu Y; Yu J; Shen R; Shan X; Zhou W; Wang J
PLoS One; 2024; 19(5):e0303513. PubMed ID: 38743748
[TBL] [Abstract] [Full Text] [Related]
19. Survival Patterns Among Patients With breast cancer in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Limenih MA; Mekonnen EG; Birhanu F; Jima BR; Sisay BG; Kassahun EA; Hassen HY
JAMA Netw Open; 2024 May; 7(5):e2410260. PubMed ID: 38743426
[TBL] [Abstract] [Full Text] [Related]
20. [Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019].
Jiang TT; Wang SY; Yin XL; Xu JH; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):461-470. PubMed ID: 38742360
[No Abstract] [Full Text] [Related]
[Next]
